Matching geography Reports matching your search in: Join Alert Me now! Receive bi-weekly email alerts on new market research Sign up today!
|
Personalized Medicine: market research reports
Personalized medicine is the use of detailed information about a patient's genotype or level of gene expression and a patient's clinical data in order to select a medication, therapy or preventative measure that is suited to that patient. The benefits of this approach are in its accuracy, efficacy, safety and speed. Research findings over the past decade in biomedical research have unfolded a series of new, predictive sciences in the fields of genomics, proteomics, metabolomics, theranostics, and cytomics. These are a new approach to drug development, as well as increasing the potential of significantly more effective diagnosis, therapeutics, and patient care.
Personalized Medicine market research reports and industry analysis
|
|
$4,500.00
|
US Personalized Cancer Genome Sequencing Marketrncos
5/1/2013 | published by: RNCOS
... the most attractive sectors due to its inherent capability of high revenue generation and efficiency in terms of personalized treatment. In order to properly analyze the virtues and significance of the US personalized cancer Whole-Genome ...
|
read more...
|
$1,200.00
|
Personalized Medicine Market Analysis
5/1/2013 | published by: RNCOS
... per individuals. The growing research applications and identification of molecular markers towards disease predisposition and progression have led to the growth of personalized medicine. Industry players have also rapidly adopted this field and are progressing ...
|
read more...
|
$1,200.00
|
Genetic Testing Market Outlook to 2017
5/1/2013 | published by: RNCOS
... 140-page report. On account of our analysis of the past and present market trends; drivers; and existing strengths and challenges; forecast for genetic testing has been drawn, according to which, the market is likely to ...
|
read more...
|
$1,200.00
|
|
|
$4,650.00
|
Cancer Peptides: From First-in-Class to Best-in-Class?
1/7/2013 | published by: BioSeeker Group AB
... Which targets, tumor types and companies are setting the path? What is first-in-class in the cancer peptide pipeline? Is First-in-Class the Best-in-Class? Indication expansion opportunities Drug repositioning opportunities Which pathways are targeted, by what and ...
|
read more...
|
$3,675.00
|
Breast Cancer Therapies Markets
11/1/2012 | published by: TriMark Publications
... such barriers to entry as a stringent regulatory environment and the incursion of cost containment within oncology. Breast Cancer Therapies Markets provides comprehensive information on major and minor shapers of the breast cancer drug treatment ...
|
read more...
|
$3,400.00
|
Personalized Medicine Partnering Terms and Agreements
10/1/2012 | published by: Current Partnering
... to the personalized medicine partnering deals and agreements entered into by the worlds leading healthcare companies. The report provides a detailed understanding and analysis of how and why companies enter personalized medicine partnering deals. The ...
|
read more...
|
$4,995.00
|
Personalized Medicine - A Global Market Overview
8/15/2012 | published by: Industry Experts
... factor, since everybody wants caregivers who can comprehend an individual’s problems. The day is not very far when this level of personal or individual understanding between a patient and a doctor would be much deeper ...
|
read more...
|
$3,600.00
|
|
|
$1,970.00
|
|
|
$1,900.00
|
The Impact of Health and Wellness on Products and Services
6/13/2012 | published by: Frost & Sullivan
... and openness and transparency - have been discussed. These four have been shortlisted among the others because greener products would have higher acceptance and increased demand, digitalization would be the key to reduce growing healthcare ...
|
read more...
|
$6,000.00
|
|
|
$1,900.00
|
White Paper: Tests That Personalize Show Faster Revenue Growth
4/6/2012 | published by: Kalorama Information
... growth than the IVD industry standard. The White Paper defines Personalized Medicine Diagnostics and provides examples of growth rates of personalized tests. This brief White Paper is based on information in Kalorama Information's full market ...
|
read more...
|
|
Personalized Medicine: Companies, Trends and World Market
4/1/2012 | published by: Takeda Pacific
... report examines key market segments such as targeted drugs and key personalized medicine diagnostics, including companion diagnostic IVDs, LDTs, diagnostic services and related tools or technologies. Many people already know about DNA, genes and the ...
|
read more...
|
$2,495.00
|
|
|
$500.00
|
|
|
$3,500.00
|
|
|
$3,400.00
|
Personalized Medicine for Cancer
9/30/2011 | published by: GlobalData
... The report also provides insights on the companion diagnostics and marketed personalized drugs for cancer. Scope The report provides information on the concept of personalized medicines, Challenges in development of personalized medicine and Benefits of ...
|
read more...
|
$500.00
|
|
|
$4,600.00
|
Personalized Medicine Partnering Terms & Agreements
4/1/2011 | published by: Current Partnering
... understanding and analysis of how and why companies enter personalized medicine partnering deals. The majority of deals are discovery or development stage whereby the licensee obtains a right or an option right to license the ...
|
read more...
|
$4,995.00
|
|
|
$3,285.00
|
|
|
$3,500.00
|
|
|
$3,900.00
|
Conference Documentation: Personalised Medicine
10/12/2010 | published by: SMI Publishing, Ltd
... latest in science, R&D, business strategies and legal issues for developing personalised therapeutics, and successfully introducing them to the marketplace. Covering various approaches towards developing personalised therapeutics - biomarkers, pharmacogenomics, pharmacogenetics and stem cells, the ...
|
read more...
|
$800.00
|
|